Skip to main content

M Mar Mañu Pereira

Head of research Lab in rare anemia disorders - Senior researcher Scientific Director of ERN-EuroBloodNet Coordinator of the European platforms for patients registries in hematology ENROL and in rare anemia disorders RADeep

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

M Mar Mañu Pereira

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Head of research Lab in rare anemia disorders - Senior researcher Scientific Director of ERN-EuroBloodNet Coordinator of the European platforms for patients registries in hematology ENROL and in rare anemia disorders RADeep

Head of research Lab in rare anemia disorders at VHIR - 2018 - Currently
Institut de Recerca contra la Leucèmia Josep Carreras - 2016-2018
Institut d'Investigacions Biomèdiques August Pi i Sunyer / Hospital Clínic de Barcelona - 2002-2016
Dr in BioMedicine 2009

Projects

IMPACT- AML

IP: M Mar Mañu Pereira
Collaborators: IMPACT- AML, Reidel , Sara Isabel, Sara Isabel Reidel, Ferran Balbastre Ubeda, Daiana Natali Lopez
Funding agency: EUROPEAN COMMISSION
Funding: 253750
Reference: IMPACT-AML_HE--MISS-CANCER2022
Duration: 01/04/2023 - 31/03/2028

SYNTHEMA: Synthetic generation of hematological data over federated computing frameworks

IP: M Mar Mañu Pereira
Collaborators: Reidel , Sara Isabel, SYNTHEMA: Synthetic generation of hematological data over federated computing frameworks , Sara Isabel Reidel, SYNTHEMA: Synthetic generation of hematological data over federated computing frameworks
Funding agency: EUROPEAN COMMISSION
Funding: 435938
Reference: SYNTHEMA_HE-HLTH22_IND13
Duration: 01/12/2022 - 30/11/2026

ENABLING PERSONALIZED MEDICINE OF SICKLE CELL DISEASE PATIENTS BASED ON INTEGRATIVE DIAGNOSIS OF NEW GENERATION METHODOLOGIES

IP: M Mar Mañu Pereira
Collaborators: Pablo Velasco Puyó, Bárbara Tazón Vega, Maria Cristina Díaz de Heredia Rubio, Thaïs Murciano Carrillo, Victoria Gutierrez Valle, Amira Idrizovic
Funding agency: Instituto de Salud Carlos III
Funding: 99220
Reference: PI20/01454
Duration: 01/01/2021 - 30/06/2025

ERICA - European Rare dIsease research Coordination and support Action

IP: M Mar Mañu Pereira
Collaborators: ERICA - European Rare dIsease research Coordination and support Action , Raquel Mosull del Campo
Funding agency: EUROPEAN COMMISSION
Funding: 105250
Reference: ERICA_H2020-SC1-BHC-2020
Duration: 01/03/2021 - 28/02/2025

Related news

The study analyzes the impact of COVID-19 on people with rare red blood cell disorders, identifying risk factors for severe forms of the disease.

The association, once again, has shown its commitment to oncological research with a donation of €19,197 to the Cancer and Hematological Diseases Group for Children at VHIR.

The prestigious journal The Lancet has published the results of this study, which is the result of more than 20 years of pre-clinical research and 7 years of patient follow-up.

Related professionals

Mercedes Martinez Mansilla

Mercedes Martinez Mansilla

Research technician
Translational Molecular Pathology
Read more
Ana Sarrias Gimenez

Ana Sarrias Gimenez

Postdoctoral researcher
Biomedical Research in Urology
Read more
Laia Sanchez i Trilles

Laia Sanchez i Trilles

Read more
Arnau Noguera Segura

Arnau Noguera Segura

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.